Phosphoramidate alkylator prodrugs
US8664204B2 · kind B2 · utility
1Cited by
31References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 12, 2013 |
| Grant date | Mar 4, 2014 |
| Priority date | — |
| Expiry date | Jul 12, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K51/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.